ReviewFrontiers in pharmacology2016

High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease.

Elizabeth M Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.